US FDA News: FDA approves treatment for two rare types of non-Hodgkin lymphoma

FDA approves new drug for the treatment of adults with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy
Read more: FDA approves treatment for two rare types of non-Hodgkin lymphoma